WO1997039029A3 - An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof - Google Patents
An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof Download PDFInfo
- Publication number
- WO1997039029A3 WO1997039029A3 PCT/US1997/006732 US9706732W WO9739029A3 WO 1997039029 A3 WO1997039029 A3 WO 1997039029A3 US 9706732 W US9706732 W US 9706732W WO 9739029 A3 WO9739029 A3 WO 9739029A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- surface antigen
- antigenic epitope
- determinant
- peptide
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
- G01N33/5764—Hepatitis B surface antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP09537434A JP2000514643A (en) | 1996-04-18 | 1997-04-18 | Antigenic epitope of a-determinant of hepatitis B surface antigen and its use |
EP97921323A EP0906337A2 (en) | 1996-04-18 | 1997-04-18 | AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63542896A | 1996-04-18 | 1996-04-18 | |
US08/635,428 | 1996-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997039029A2 WO1997039029A2 (en) | 1997-10-23 |
WO1997039029A3 true WO1997039029A3 (en) | 2001-06-28 |
Family
ID=24547753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/006732 WO1997039029A2 (en) | 1996-04-18 | 1997-04-18 | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0906337A2 (en) |
JP (1) | JP2000514643A (en) |
CA (1) | CA2251904A1 (en) |
WO (1) | WO1997039029A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0919568A1 (en) | 1997-12-01 | 1999-06-02 | Sorin Diagnostics S.r.l. | Escape mutant of the surface antigen of hepatitis B virus |
EP1111388A1 (en) * | 1999-12-23 | 2001-06-27 | Universiteit Gent | Interaction between CD14 and HBV components |
MXPA06013933A (en) | 2004-06-07 | 2007-01-26 | Chiron Corp | Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same. |
JP4948783B2 (en) * | 2005-05-18 | 2012-06-06 | シスメックス株式会社 | Anti-HBs monoclonal antibody |
EP3308798B1 (en) * | 2012-06-11 | 2020-09-09 | Xiamen University | Polypeptides and antibodies for treating hbv infection and related diseases |
WO2017059878A1 (en) | 2015-10-07 | 2017-04-13 | Humabs Biomed Sa | Antibodies that potently neutralize hepatitis b virus and uses thereof |
CA3053591C (en) | 2017-02-17 | 2023-03-21 | Xiamen University | Polypeptide carrier for presenting target polypeptide and uses thereof |
JP2023527918A (en) * | 2020-06-08 | 2023-06-30 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Anti-HBV antibody and method of use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0155146A2 (en) * | 1984-03-09 | 1985-09-18 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
JPH045300A (en) * | 1990-04-20 | 1992-01-09 | Tetsuo Nakamura | Viral hepatitis type b vaccine and antibody specific to hbs antigen |
WO1995016704A1 (en) * | 1993-12-16 | 1995-06-22 | Smithkline Beecham Biologicals S.A. | Hepatitis b virus peptides |
-
1997
- 1997-04-18 WO PCT/US1997/006732 patent/WO1997039029A2/en not_active Application Discontinuation
- 1997-04-18 CA CA002251904A patent/CA2251904A1/en not_active Abandoned
- 1997-04-18 EP EP97921323A patent/EP0906337A2/en not_active Withdrawn
- 1997-04-18 JP JP09537434A patent/JP2000514643A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0155146A2 (en) * | 1984-03-09 | 1985-09-18 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
JPH045300A (en) * | 1990-04-20 | 1992-01-09 | Tetsuo Nakamura | Viral hepatitis type b vaccine and antibody specific to hbs antigen |
WO1995016704A1 (en) * | 1993-12-16 | 1995-06-22 | Smithkline Beecham Biologicals S.A. | Hepatitis b virus peptides |
Non-Patent Citations (6)
Title |
---|
CHEMICAL ABSTRACTS, vol. 113, no. 9, 27 August 1990, Columbus, Ohio, US; abstract no. 76023, MUNEKATA, EISUKE ET AL: "Epitope mapping in the protein of hepatitis B-virus" XP002044689 * |
DATABASE WPI Section Ch Week 9208, Derwent World Patents Index; Class B04, AN 92-060743, XP002044690 * |
FERNANDEZ-DE-COSSIO, MARIA E. ET AL: "Murine monoclonal antibodies specific for the HBsAg a determinant", BIOTECNOL. APL. (1995), 12(2), 89-90 CODEN: BTAPEP;ISSN: 0864-4551, 1995, XP002044687 * |
H. OHNUMA ET AL.: "Synthetic Oligopeptides Bearing a Common or Subtypic Determinant of Hepatitis B Surface Antigen", JOURNAL OF IMMUNOLOGY, vol. 145, no. 7, 1 October 1990 (1990-10-01), BALTIMORE US, pages 2265 - 2271, XP002044688 * |
PEPT. CHEM. (1990), VOLUME DATE 1989, 27TH, 281-4 CODEN: PECHDP;ISSN: 0388-3698, 1990 * |
QIU, XIAOXING ET AL: "Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen", J. IMMUNOL. (1996), 156(9), 3350-6 CODEN: JOIMA3;ISSN: 0022-1767, 1 May 1996 (1996-05-01), XP002044686 * |
Also Published As
Publication number | Publication date |
---|---|
CA2251904A1 (en) | 1997-10-23 |
JP2000514643A (en) | 2000-11-07 |
EP0906337A2 (en) | 1999-04-07 |
WO1997039029A2 (en) | 1997-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2025598A1 (en) | Chimaeric hepadnavirus core antigen proteins | |
AU9052891A (en) | Proteins with changed epitopes and methods for the production thereof | |
WO1995029193A3 (en) | Melanoma antigens | |
EP0992580A3 (en) | Immunodominant human T-cell epitopes of Hepatitis C virus | |
KR910016343A (en) | Serum Reactive Epitopes of Human Papillomavirus (HPV) 16 Protein | |
EP0328403A3 (en) | Synthetic peptides related to the hiv-gp120-env-protein, and their use | |
CA2078694A1 (en) | Hepatitis b vaccine | |
AU1353295A (en) | Peptides derived from a retrovirus of the HIV group, and their use | |
ES2068907T3 (en) | NUCLEOTIDE SEQUENCES CODING A PROTEIN WITH UREASIC ACTIVITY. | |
CA2175567A1 (en) | Chimeric proteins comprising borrelia polypeptides: uses therefor | |
BR9810907A (en) | Monoclonal and polyclonal antibodies, peptide capable of generating an antibody, immunogenic agent, nucleotide sequence, pharmaceutical composition, use of at least one antibody, diagnostic kit, and process for preparing an immunogenic agent | |
DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
WO1997039029A3 (en) | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof | |
DE3380629D1 (en) | Region-specific determinants for vitamin k dependent bone protein | |
NZ592340A (en) | A method for making a virus vaccine compising Replikin peptides | |
CA2084386A1 (en) | Hiv antigen | |
NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
JPS5657753A (en) | Novel glucagon fragment, and its use | |
EP0177814A3 (en) | Peptide antibodies and their use in detecting oncogene products | |
IE883545L (en) | Peptide structures, immunogens containing them and their uses in the control of fertility | |
WO1990012807A3 (en) | Purified, highly specific antibodies against gene products including retinoblastoma and method | |
CA2085191A1 (en) | Vaccines based on modified type 1 bovine herpesviruses | |
AU6393990A (en) | Hiv related peptides | |
AU1464488A (en) | Human rhinovirus peptides | |
AU6306390A (en) | Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2251904 Country of ref document: CA Ref country code: CA Ref document number: 2251904 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997921323 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997921323 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997921323 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |